Disclosures for "KHN702, a Novel Selective hNav1.8 Inhibitor for Pain Therapy"
-
Ms. Liu has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
-
Dr. Huang has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
-
Dr. Mu has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd..
-
Mr. Yu has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
-
Miss Cai has received personal compensation for serving as an employee of Chengdu Kanghong Pharmaceutical Garoup Co.,Ltd..
-
Dr. Bai has received personal compensation for serving as an employee of Chengdu Kanghong Pharma Co., Ltd..
-
Dr. Ke has received personal compensation for serving as an employee of chengdu Kanghong Pharmaceutical Group Co., Ltd.